Interestingly, apatinib, another VEGFR-2 inhibitor had clinical activity (partial response) in a case of DSRCT treated with prior surgery and non-conventional treatment with a follow up time of 4 months (33). This evidence concerns the gene KDR and desmoplastic small round cell tumor.